Skip to content
DataLookout
Menu

PFACNA-AFNCT07171463

Pulsed Field Ablation With Concomitant Radiofrequency Cardioneuroablation in Patients With Paroxysmal Atrial Fibrillation

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 29 words
    • Trial completed
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Recurrence of atrial fibrillation
Timeframe: 12 months post-procedure

Secondary (2)

Intraprocedural bradyarrhythmic episodes
Requirement for intraprocedural cardioversion

Arms and interventions

PFA with selective thermal ganglion ablationExperimental

Participants will undergo pulmonary vein isolation using a point-by-point bipolar pulsed-field ablation. In addition, selective thermal ablation using radiofrequency energy will be performed at the anterior aspect of the right superior pulmonary vein, corresponding to the anatomical region of the superior paraseptal parasympathetic ganglion.

Standard PFA pulmonary vein isolationActive comparator

Participants will undergo pulmonary vein isolation using the same point-by-point bipolar PFA system without any additional thermal applications.

Procedures: Pulmonary Vein Isolation using Point-by-Point Bipolar Pulsed-Field Ablation, Selective Radiofrequency Ablation of the Superior Paraseptal Parasympathetic Ganglion

Sites

1 site in 1 country

  • St. Joseph's Heart Rhythm CenterRzeszów, Podkarpackie Voivodeship, Poland